About this event

Association for Vascular Access (AVA) — Event Deep Research Description

The Association for Vascular Access (AVA) conference is a specialized healthcare and clinical education event focused on vascular access practices—spanning peripheral IVs, central venous access, PICC lines, midlines, hemodialysis access considerations, and evidence-based workflow improvements for safer, more reliable patient care. Unlike broad general medical conferences, AVA’s audience is concentrated around a clear clinical domain: vascular access, infusion therapy, and related quality, safety, and outcomes initiatives.

For a data-and-targeting research view, AVA is most valuable where the product or service directly supports vascular access delivery, device usage, infusion therapy workflows, clinical training, nursing practice standardization, audit/quality programs, infection prevention outcomes, and vendor collaboration with hospitals and infusion networks.

Assumptions & How We Frame This Research

• Event type: Clinical education conference + professional association meeting + vendor exhibit environment.
• Primary audience: Vascular access clinicians and decision-influencers (nursing leadership, vascular access team leads, infusion therapy leaders, quality/safety stakeholders).
• Core theme: Better outcomes through evidence-based vascular access practices, training, standardization, and quality measurement.

1️⃣ Who Attends (Buyers / Attendees)

AVA attracts a mix of clinical practitioners, operational leaders, and healthcare stakeholders who influence the adoption of vascular access-related products, training programs, and protocols. While some attendees are not “buyers” in a procurement sense, they strongly influence purchasing priorities by specifying clinical requirements, forming product evaluations, and shaping standard-of-care protocols.

Main attendee groups (what we would target as “buyer-like” profiles):

• Vascular access team leads and champions: Nurses or clinical leaders responsible for vascular access programs, cannulation services, and line placement workflow.
• Infusion therapy leadership: Infusion nurses, infusion directors, and clinical educators supporting infusion services.
• Hospital nursing leadership: Nursing directors/managers overseeing inpatient/outpatient infusion, critical care, oncology infusion centers, or IV therapy programs.
• Quality and patient safety stakeholders: Roles tied to safety initiatives, infection prevention goals, and vascular access outcomes metrics.
• Clinical educators and training coordinators: People responsible for competency development, protocol adherence, and staff training.
• Clinicians in vascular access specialties: Nurse practitioners, physicians, and allied health professionals involved in line placement and vascular access outcomes.
• Vendor and distributor decision influencers: Exhibit participants whose teams work with hospitals, infusion centers, and dialysis networks.
• Service and program leaders: Infection prevention coordinators, clinical program managers, and care pathway owners tied to catheter/IV outcomes.

In short, AVA’s “buyer-like” attendees are those who own or heavily influence clinical protocols and vascular access workflows. For most products that fit AVA’s domain, the most valuable targets tend to be clinical leaders and program owners rather than only general procurement personnel.

2️⃣ Where the Show Is Happening + Attendee Geographic Origin

Because AVA is a professional association conference, it typically draws a strong base from the United States with additional representation from Canada and other countries where vascular access programs and infusion services align with AVA’s clinical standards and education agenda.

Geographic pattern we typically expect:

• United States dominance: Most attendees come from U.S. health systems, academic hospitals, outpatient infusion centers, and dialysis-related care pathways.
• Regional clustering: Heaviest presence is commonly from surrounding states/regions of the host venue due to travel convenience for clinical teams.
• International participation: Generally smaller but meaningful, with clinicians and vendors who work with global device standards and evidence-based vascular access practices.

Best targeting implication: We recommend structuring attendee lists by “care setting” (acute care hospital, outpatient infusion, oncology centers, dialysis-adjacent care pathways) and by organizational influence role (program owners, education leaders, quality/safety leads).

3️⃣ Audience Reach (Local / National / Global)

AVA’s reach is best described as national, with selective international participation. The event is focused enough that attendees return for domain-specific education, clinical networking, and program benchmark discussions rather than broad general-interest content.

• Local: Moderate effect near the host city (local health systems send teams).
• National: Strong, because the conference is directly tied to vascular access practice standards and training.
• Global: Limited but present, especially where international manufacturers/distributors and cross-border clinical professionals engage.

4️⃣ Sample Buyer Company Names (Buyers ONLY) + Websites

Below is a sample list of buyer-oriented organizations (health systems, infusion networks, oncology care systems, dialysis-related networks, and major healthcare service environments) that typically have vascular access programs, infusion services, and clinical safety initiatives that align with AVA.

Note: We structure this as “buyer-fit targets” (organizations likely to implement vascular access standards), not as a random exhibitor list. We would refine these further once we know the client’s specific product category and use case.

Priority	Company	Website	Best Title to Target	Why This is a Good Buyer Fit
1	HCA Healthcare	https://www.hcahealthcare.com	Director, Infusion Services / Vascular Access Program Director	Large hospital network with standardized clinical programs where vascular access protocols and education can be operationalized across sites.
2	Cleveland Clinic	https://my.clevelandclinic.org	Clinical Nursing Director, Infusion Therapy / Vascular Access Lead	High-complexity care and strong emphasis on clinical outcomes and protocol standardization supports vascular access program improvements.
3	Mayo Clinic	https://www.mayoclinic.org	Program Manager, Nursing Education / Vascular Access Team Lead	Education-focused environment where competency-based training and evidence-based vascular access practices drive adoption.
4	Johns Hopkins Medicine	https://www.hopkinsmedicine.org	Director, Clinical Programs / Vascular Access Clinical Lead	Academic and research infrastructure creates strong demand for evidence-based device workflows and outcome tracking.
5	University of Texas MD Anderson Cancer Center	https://www.mdanderson.org	Infusion Services Director / Oncology Nursing Program Lead	Oncology infusion volumes typically rely heavily on reliable vascular access—ideal fit for devices and training improving line performance.
6	Tenet Healthcare	https://www.tenethealth.com	VP, Clinical Operations / Nursing Director, Infusion & Vascular Access	Multi-hospital scale supports standardized initiatives and consistent vascular access workflows across facilities.
7	Kaiser Permanente	https://about.kaiserpermanente.org	Clinical Program Director, Infusion Therapy / Quality & Safety Nurse Leader	Integrated care model and quality programs align strongly with vascular access outcomes, safety metrics, and standard-of-care adoption.
8	Children’s Hospital of Philadelphia (CHOP)	https://www.chop.edu	Clinical Nursing Director / Vascular Access Program Lead	Pediatric vascular access requires specialized protocols; CHOP is a strong target for training, education, and device workflow optimization.
9	St. Jude Children’s Research Hospital	https://www.stjude.org	Director, Infusion Services / Clinical Practice Coordinator	High-acuity pediatric oncology care creates consistent demand for reliable vascular access and clinician education programs.
10	DaVita (Dialysis Networks)	https://www.davita.com	Clinical Services Director / Vascular Access-Related Program Manager	Dialysis and vascular access are tightly connected; vascular access workflows and safety outcomes are core operational priorities.
11	Fresenius Medical Care	https://www.fmcna.com	Clinical Program Manager / Vascular Access Solutions Lead	Direct relevance to dialysis and vascular access; strong alignment with clinical education, process standardization, and device adoption.
12	US Renal Care	https://www.usrenalcare.com	Director of Clinical Operations / Quality Nurse Leader	Operational ownership of clinical outcomes and vascular access processes makes it an AVA-aligned target.
13	TriHealth	https://www.trihealth.com	Director, Infusion Center / Vascular Access Program Manager	Regional hospital system with strong inpatient/outpatient services where infusion therapy and vascular access programs are active.
14	Providence (Healthcare)	https://www.providence.org	Nursing Leadership, Infusion / Clinical Safety Program Owner	Large multi-state footprint typically includes vascular access standards and quality initiatives that benefit from domain-specific solutions.
15	CommonSpirit Health	https://www.commonspirithealth.org	Director, Clinical Quality / Nursing Program Lead, Infusion & Vascular Access	System-wide quality and operational standardization makes vascular access improvements measurable and scalable.
16	Ascension	https://www.ascension.org	Vice President, Clinical Excellence / Vascular Access Program Director	Strong clinical excellence focus and large clinical footprint are aligned with evidence-based vascular access programs.
17	Mount Sinai Health System	https://www.mountsinai.org	Director of Nursing, Infusion Therapy / Vascular Access Clinical Lead	High-volume specialties and outcomes-driven model support adoption of improved vascular access processes and training.
18	Baptist Health (Multiple States)	https://www.baptisthealth.com	Nursing Leadership, Infusion Services / Vascular Access Team Lead	Regional network with clinical operations that benefit from consistent vascular access protocols and staff competency improvement.
19	Memorial Sloan Kettering Cancer Center	https://www.mskcc.org	Infusion Services Manager / Oncology Nursing Program Lead	Oncology infusion reliance on vascular access makes it a strong target for solutions that reduce complications and improve reliability.
20	Vanderbilt University Medical Center	https://www.vumc.org	Clinical Education Program Lead / Vascular Access Team Coordinator	Research and clinical education culture supports adoption of standardized vascular access practices and structured training programs.

Top first samples to prioritize (coverage strategy): DaVita, HCA Healthcare, Cleveland Clinic, MD Anderson, Fresenius Medical Care. This mix covers dialysis/vascular access adjacencies, large hospital networks, and oncology infusion reliance—three major demand anchors for AVA-style solutions.

5️⃣ Job Profiles, Industries & Event Type

Best job profiles to target in a database build

• Director, Vascular Access / Vascular Access Program Director
• Infusion Therapy Director / Infusion Services Director
• Clinical Operations Director (Nursing), Infusion & Access Services
• Manager, Nursing Education / Clinical Education Coordinator
• Vascular Access Team Lead / Program Coordinator
• Quality & Patient Safety Nurse Leader (Infusion/Access outcomes)
• Infection Prevention Coordinator (vascular access-related risks)
• Clinical Informatics / Clinical Workflow Improvement Lead (if the solution is workflow/software)
• Biomedical Engineering liaison (for device integration, if applicable)
• Purchasing influence roles (where present): Clinical Procurement Partner, Clinical Supply Chain Specialist

Industries to align (based on the provided industry list)

• Hospital & Health Care
• Medical Devices
• Pharmaceuticals (indirectly, via infusion therapy settings)
• Biotechnology (where infusion/clinical programs integrate biotech-related solutions)
• Research
• Professional Training & Coaching (if the client provides training/certification or competency programs)
• Education Management (if the client provides clinical education content or curriculum support)
• Events Services (only for conference organizers/partners; less core for buyer intent)

Event type mapping

• Clinical education conference (training, competency, evidence-based practice)
• Professional association meeting (networking among vascular access specialists)
• Exhibit floor environment (vendors present devices, supplies, services, and education tools)
• Quality and outcomes theme (reducing complications, improving reliability, standardizing workflows)

6️⃣ Estimated Attendance (Expected Total Footfall)

The expected footfall for AVA can vary year to year depending on venue size, program scope, and parallel sessions. For planning purposes, we can treat AVA as a mid-size to moderately large specialized healthcare conference.

Practical planning estimate (industry typical range):

• Expected total attendance: ~1,200 to 2,500 participants
• Clinical depth: High concentration of vascular access-focused roles
• Exhibit engagement: Meaningful vendor traffic, especially around device, supply, training, and program solutions

For buyer-density planning: AVA is not a “mass consumer show.” The value is in relevance. The attendee list quality is usually strong because most people attending are operationally connected to vascular access programs.

7️⃣ Key Focus Areas & Buyer Engagement

Key focus areas we expect to see emphasized at an AVA conference:

• Evidence-based vascular access practices: Standard-of-care guidance, best practices, and outcomes benchmarking.
• Device and supply selection: Choosing appropriate access approaches and line-related equipment for care settings.
• Competency-based training: Building staff skills, reducing variation, and improving reliability in line placement and maintenance.
• Patient safety & complication reduction: Minimizing risks such as infections, infiltration/extravasation, and access failure patterns.
• Workflow standardization: Aligning roles, protocols, and scheduling to reduce delays and variation.
• Quality measurement: Reporting outcomes and using data to drive continuous improvement.
• Interdisciplinary collaboration: Nursing, clinical education, quality teams, infusion services, and sometimes radiology/interventional stakeholders.

How we position engagement for maximum conversion:

• Speak to outcomes, not just products: Frame messages around reduced complications, improved access reliability, and better patient experience metrics.
• Match to program ownership roles: We prioritize targets who can standardize training or protocols across units/hospitals.
• Offer “implementation-ready” value: Provide onboarding templates, training integration ideas, workflow support, and measurement suggestions.
• Segment by care setting: Oncology infusion, acute care nursing, outpatient infusion, and dialysis-adjacent care require different workflows and requirements.

8️⃣ Client Product Review Alignment (We Need the Client Website)

We can refine the “best buyers” shortlist and the most relevant titles once we review the client’s product and intended use case on the client’s website. Please share the client website so we can identify which AVA-aligned buyer segments match best.

What we will do after we receive the client website:

• Map the product category to AVA focus areas (device, training, workflow, quality measurement, safety program, infusion support).
• Select the most relevant buyer-like titles (program directors, vascular access leads, infusion leadership, education leads, quality/safety owners, clinical supply chain influencers where relevant).
• Prioritize industries using your provided industry list (for example: Hospital & Health Care, Medical Devices, Professional Training & Coaching, Research).
• Generate a high-priority buyer table with best-fit titles per organization based on product-to-use-case fit.

To speed this up: If the client sells one of the following, let us know (we can tailor instantly): vascular access devices/supplies, PICC/midline-related products, infection prevention solutions, infusion workflow tools, training/certification programs, or analytics/quality dashboards.

9️⃣ Final Recommendation (Is AVA Good for Attendee/Buyer Research?)

Yes—AVA is typically an excellent event for deep buyer-intent research when the client product aligns with vascular access clinical workflows, safety outcomes, and training/standardization initiatives. The attendee base is specialized, which improves relevance and reduces wasted outreach compared to broad healthcare trade shows.

Best buyer segments to collect for AVA-aligned outreach:

• Vascular access program directors/leads
• Infusion therapy leadership and infusion center managers
• Nursing education and competency training coordinators
• Quality, safety, and infection prevention leadership tied to access outcomes
• Oncology infusion program stakeholders (if the client focuses on infusion reliability)
• Dialysis network clinical program leaders (if the client addresses access stability/safety)

Quality rating for AVA buyer-fit attendee research (domain relevance): 8.5/10 (high clinical alignment). Caution: The event is specialized, so buyer-fit depends heavily on whether the client product directly supports vascular access delivery, training, workflow standardization, or outcomes measurement.

Optional Next Step (So We Can Produce a “Best Buyers” List for Your Client)

Share your client website and we will respond with: (1) a refined buyer shortlist (15–30 top buyer accounts), (2) the best matching job titles per account, (3) suggested AVA-aligned industries from your provided industry list, and (4) the outreach angle mapped to AVA’s focus areas for your exact product category.